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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).SUMMARYDistinguishing between perivascular cell types remains a hurdle in vascular biology due to overlapping marker expressions and similar
functionalities. Clarifying and defining heterogeneities in vitro among perivascular cells could lead to improved cell-based tissue regen-
eration strategies and a better understanding of human developmental processes. We studied contractile vascular smooth muscle cells
(vSMCs), synthetic vSMCs, and pericytes derived from a common human pluripotent stem cell source. Using in vitro cultures, we
show unique cell morphology, subcellular organelle organization (namely endoplasmic reticulum, mitochondria, and stress fibers),
and expression of smoothmuscle myosin heavy chain and elastin for each cell type.While differences in extracellular matrix deposition
and remodeling were less pronounced, the multipotency, in vivo, migratory, invasion, and contractile functionalities are distinctive for
each cell type. Overall, we define a repertoire of functional phenotypes in vitro specific for each of the human perivascular cell types,
enabling their study and use in basic and translational research.INTRODUCTION
The vasculature is a multicellular system in which each cell
type plays an important and indispensible role in its func-
tion. The inner lining of endothelial cells (ECs), which
are in direct contact with the blood, is surrounded and
supported by perivascular cells—either vascular smooth
muscle cells (vSMCs) or pericytes. vSMCs surround larger
vessels such as arteries and veins, whereas pericytes typi-
cally surround smaller microvessels and capillaries (Alberts
et al., 2002). The disparate vessel locations for each perivas-
cular cell type suggest that further differences exist that
should be investigated and better understood in vitro in
order to appropriately rebuild blood vessels for therapeutic
applications (Dar and Itskovitz-Eldor, 2013; Wanjare et al.,
2013b).
As the vasculature’s support system, perivascular cells are
primarily responsible for imparting contractility and pro-
ducing and depositing extracellularmatrix (ECM) proteins.
Both cell types migrate to sites of angiogenesis, the growth
of blood vessels from preexisting ones, to help stabilize and
mature nascent endothelial tubes. Whether pericytes and
vSMCs function similarly in these regards and to what
extent have been unclear.
Along with the aforementioned functional similarities,
perivascular cell types also exhibit overlapping marker
expression. Adding to this complexity, neither perivascular
cell type can be distinguished by onemarker alone; instead,
a combination of markers is needed for their identification.SteFor example, both cell types have been demonstrated to ex-
press alpha smooth muscle actin (a-SMA). The expression
of a-SMA and the transmembrane chondroitin sulfate pro-
teoglycan neuron-glial 2 (NG2) help distinguish pericytes
in different vessel types (Crisan et al., 2012); pericytes
of the capillaries are NG2+a-SMA, of the venules are
NG2-a-SMA+, and of the arterioles are NG2+a-SMA+.
When cultured in vitro, however, pericytes are positive
for both of these markers. Other markers that are expressed
on both perivascular cell types include calponin and
platelet-derived growth factor receptor b (PDGFRb) (Biru-
kov et al., 1991; Dar et al., 2012).
Examining differences in perivascular cell types is further
complicated by added heterogeneities within the subtypes
(Hedin and Thyberg, 1987; Kusuma and Gerecht, 2013).
Two distinct vSMC phenotypes have been elucidated: syn-
thetic and contractile (Beamish et al., 2010; Hedin and
Thyberg, 1987; Wanjare et al., 2013a). Both participate in
neovascularization, but synthetic vSMCs predominate in
the embryo and in diseased or injured adult vessels while
contractile vSMCs predominate in healthy adult vessels.
Human pluripotent stem cells (hPSCs), including human
embryonic stem cells (hESCs) and human induced PSCs
(hiPSCs), have been widely used to study somatic cell types
due to their ability to obtain cell derivatives of identical ge-
netic backgrounds. They are known for their ability to self-
renew indefinitely in culture and to differentiate toward
every cell type, including perivascular cells (Dar and
Itskovitz-Eldor, 2013). hiPSCs are derived from a patient’sm Cell Reports j Vol. 2 j 561–575 j May 6, 2014 j ª2014 The Authors 561
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are patient specific, providing a clinically relevant pluripo-
tent cell source for therapeutic use. Indeed, we and others
have examined the derivation of both vSMCs (Drukker
et al., 2012; Ferreira et al., 2007; Wanjare et al., 2013a)
and pericytes (Dar et al., 2012; Kusuma et al., 2013; Orlova
et al., 2014).
Using a stepwise differentiation protocol, we have
demonstrated the maturation of smooth muscle-like cells
(SMLCs) (Vo et al., 2010) to synthetic vSMCs (syn-vSMCs)
and contractile vSMCs (con-vSMCs) from both hESCs and
hiPSCs (Wanjare et al., 2013a). Using a similar but distinct
stepwise differentiation protocol, we have also demon-
strated the derivation of pericytes from various hPSC lines
(Kusuma et al., 2013).
Building off of our previous studies, we sought to com-
prehensively define differences among con-vSMCs, syn-
vSMCs, and pericytes derived from a common hPSC source
in order to uncover cellular and functional differences
invitro, toward the long-termgoal of rebuildingvasculature
for therapeutic applications. For example, the quality of
tissue-engineered blood vessels is dependent on the charac-
teristics of the in vitro perivascular cells used. Current
challenges of engineering blood vessels include precise
mechanical requirements and tissue-specific cell types (Ku-
mar et al., 2011). The in vitro characterization of our hPSC-
derived perivascular cells may mediate the production of
tissue-engineered blood vessels that have the patency and
mechanical responsiveness equivalent to the native tissue
(Chan-Park et al., 2009). Of clinical relevance, the hiPSC-
BC1 line is used as the hPSC source for our studies. BC1 is
derived without viral integration and has been fully genet-
ically sequenced (Cheng et al., 2012; Chou et al., 2011).
Here, we focus on differences in perivascular cells derived
from BC1 and hESC H9 cells with respect to cellular
characteristics, protein expression, ECM deposition, and
remodeling, migration, invasion, and contractility.RESULTS
Pericytes and vSMCs Differ in Morphological Features
and Proliferation Rates
Perivascular cells were derived from hPSCs using differenti-
ation protocols from previous studies (Kusuma et al., 2013;
Vo et al., 2010; Wanjare et al., 2013a). Using this protocol,
hPSC SMLCs subjected to long-term differentiation and in
the presence of high serum and growth factors were guided
toward a synthetic fate, whereas deprivation of serum and
growth factors yielded a contractile fate (Figure 1A) (Wan-
jare et al., 2013a). Early pericytes were derived as part of a
bicellular population with early ECs named early vascular
cells (EVCs) and further differentiated toward mature peri-562 Stem Cell Reports j Vol. 2 j 561–575 j May 6, 2014 j ª2014 The Authorscytes by a selective plating strategy (i.e., removal of
collagen IV substrate and constrained adhesion time) in
the presence of high serum (Figure 1A) (Kusuma et al.,
2013). For pericytes, EVCs highly express CD105 and
CD146, while pericyte derivatives express NG2, PDGFRb,
CD44, and CD73 (Figure 1A) (Kusuma et al., 2013).
To better understand progression in differentiation, we
examined marker expression at different time points along
the differentiation of hPSCs. Over the first 6 days of differ-
entiation, the three classes of perivascular cells underwent
identical differentiation conditions. During embryonic
development, vSMCs may arise from a number of precur-
sors from different germ layers (Cheung et al., 2012; Maje-
sky, 2007). We found that expression of mesodermal genes
KDR, APLNR, and TCF21 increased over the first 6 days of
differentiation in both BC1 and H9 cell lines, whereas
expression of neural crest markers SOX1, PAX6, and
WNT1 remained stagnant (Figure S1A available online).
Additionally, WNT1 was not expressed in BC1 differenti-
ating cells. These data suggest the emergence of a meso-
dermal population. Furthermore, our day 6 differentiating
cells were assessed for the expression of markers indicative
of several intermediate lineages: neuroectoderm (nestin),
lateral plate mesoderm (KDR), paraxial mesoderm (Pax1)
(Cheung et al., 2012), early mesoderm (CD56) (Evseenko
et al., 2010), and general mesoderm (CD73) (Boyd et al.,
2009; Vodyanik et al., 2010).We found that a small fraction
of day 6 differentiating cells was positive for nestin (Fig-
ure 1B). KDR was only slightly expressed. Pax1 was not
detected via PCR or by immunofluorescence (data not
shown). Mesodermmarkers CD56 and CD73, however, ex-
hibited more pronounced expression; day 6 differentiating
cells were 72% positive for CD56 and >95% positive for
CD73. To distinguish the subsequently derived cell popula-
tions (i.e., EVCs and SMLCs), we performed flow cytometry
analysis for the aforementioned markers. After differentia-
tion toward EVCs, we observed that nestin expression was
completely abolished; however, a small fraction of SMLCs
remained nestin+ (Figure 1B). Similarly to day 6 differenti-
ating cells, EVCs exhibited >95% positive expression for
CD73, whereas CD73 expression decreased to 70% in
SMLCs. An important differentiator between EVCs and
SMLCs is the presence of vascular endothelial cadherin
(VEcad). Our previous studies demonstrated that BC1-
EVCs exhibited approximately 30% VEcad+ cells (Kusuma
et al., 2013). Contrastingly, we could not detect VEcad
expression on SMLCs (Vo et al., 2010). A similar trend of
marker expression was observed at different time points
along the differentiation of hESC line H9 (Figure S1B).
We next evaluated the differences in proliferation rates
among the hPSC-derived mature perivascular cells. As ex-
pected, hiPSC con-vSMCs exhibited low proliferation rates
because they are cultured in media containing low serum
AB
Figure 1. Characterization of Cellular
Properties of Perivascular Derivatives
(A) Schema for the differentiation procedure
to derive perivascular cells from hPSCs.
(B) Flow cytometry analysis of day 6 differ-
entiating cells, EVCs, and SMLCs. Isotype
control in gray. Results shown are represen-
tative of three independent experiments.
CIV, collagen IV.
See also Figure S1.
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hiPSC syn-vSMCs exhibited high proliferation rates
because they are cultured in media containing 10% serum
(Figure 2A). Although hiPSC pericytes were cultured using
media containing 10% serum, they exhibited contact in-
hibited proliferation and grew in cell colonies (Figures 2A
and 2B). Next, we evaluated the morphological features
after culture on 2D surfaces (Figure 2B). While both
hiPSC vSMC types spread evenly throughout the Petri
dish, hiPSC pericytes arranged themselves into colony-
like structures. hiPSC con-vSMCs displayed the largest
cell areas and nuclei sizes compared to hiPSC syn-vSMCs
and hiPSC pericytes (Figure 2C). hESC derivatives ex-
hibited the same trend (Figure S1C). Indeed, a phenotypic
switch from syn-vSMCs to con-vSMCs has been correlated
with smaller nuclei and a decrease in proliferation (Chen
et al., 1997).SteThere were stark differences in endoplasmic reticulum
(ER), mitochondria location, stress fibers, and the pres-
ence of autophagosomes observed between pericytes and
vSMCs. As previously described, hiPSC con-vSMCs contain
dilated ER, while hiPSC syn-vSMCs contain nondilated ER
(Wanjare et al., 2013a) (Figure 2D). On the other hand,
hiPSC pericytes (as well as cell-line placental pericytes) con-
tained both dilated and nondilated ER (Figure 2D; Fig-
ure S2A). The mitochondria of hiPSC pericytes were in
close proximity to the nucleus in contrast to vSMCs, whose
mitochondria were located further away from the nucleus.
With respect to stress fibers, only con-vSMCs had stress
fibers located throughout the entire cell body. Both hiPSC
syn-vSMCs and hiPSC pericytes primarily had stress fibers
located at the basal lateral surface (Figure 2D). Pericytes
also had autophagosomes present, whereas both hiPSC
syn-vSMCs and con-vSMCs did not (Figure 2D; Figure S2).m Cell Reports j Vol. 2 j 561–575 j May 6, 2014 j ª2014 The Authors 563
Figure 2. Analysis of hPSC-Derived Perivascular Cells
Derivatives were analyzed for (A) proliferation using (i) stain for Ki67 (red; nuclei in blue) and (ii) corresponding image quantification,
(B) morphology using (i) light microscopy and (ii) FM4-64 membrane stain (red) and DAPI (blue), (C) corresponding image quantification
of (i) cell and (ii) nuclei area, and (D) subcellular organelle organization using transmission electron microscopy. CIV, collagen type IV;
ER, endoplasmic reticulum; mitoch, mitochondria. Scale bars in (D) are 1 mm. Results shown from three independent experiments. All
graphical data are reported as mean ± SEM. *p < 0.05, **p < 0.01, and ***p < 0.001. See also Figure S2.
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We next examined the expression and localization of spe-
cific cytoskeleton proteins that have been reported to
distinguish vSMCs and pericytes. Stress fibers are bundles
of actin filaments that are important in mechanotransduc-
tion of adherent cells by anchoring to substrates and
creating isometric tension (Deguchi et al., 2006). Perivascu-
lar cell contraction is associated with a more filamentous
cytoskeleton within the cells. Accordingly, the hiPSC
con-vSMCs demonstrated elevated stress fibers per cell
compared to both hiPSC syn-vSMCs and hiPSC pericytes,564 Stem Cell Reports j Vol. 2 j 561–575 j May 6, 2014 j ª2014 The Authorswhich had significantly fewer stress fibers per cell (Fig-
ure 3A, i and ii; additional fields of view in Figure S3).While
differences in a-SMA expression and organization could
not be observed, calponin expression was upregulated in
hiPSC pericytes (Figure 3A, i and iii; Figure S3).
The cell-surface proteins NG2 and PDGFRb are also
commonly associated with perivascular cells. The proteo-
glycan NG2 has been shown to be widely expressed by
perivascular cells in both vasculogenic and angiogenic
vasculature (Ozerdem et al., 2001). While NG2 is an appro-
priate marker for identifying pericytes in microvessels, it is
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variety of vSMC markers (Ozerdem et al., 2001). Interest-
ingly, profuse stress fibers were observed with the expres-
sion of NG2 protein only in hiPSC con-vSMC cultures
(Figure 3B, i). Indeed, NG2 mRNA expression in hiPSC
con-vSMCs was significantly elevated compared to hiPSC
syn-vSMCs and hiPSC pericytes (Figure 3B, ii). Similarly,
aortic vSMCs exhibited NG2 expression with profuse
stress fibers compared to placental pericytes (Figure 3B, ii;
Figure S4A). We observed differences in the expression of
PDGFRb in our hiPSC derivatives. hiPSC con-vSMCs
exhibited elevated PDGFRb mRNA expression that had
a punctuate membrane expression as well as nuclear
expression (Figure 3C, i and ii) comparable to aortic vSMCs
(Figure S4B).
The mature vSMCmarker SMMHC is associated with the
contractile vSMC phenotype (Babu et al., 2000; Patel et al.,
2006). hiPSC con-vSMCs exhibited elevated SMMHC
expression compared to hiPSC syn-vSMCs and pericytes
(Figure 3C). Correspondingly, aortic vSMCs exhibited
elevated SMMHC expression and SMMHC stress fibers,
while placental pericytes did not (Figure 3C; Figure S4B).
We further evaluated mRNA and protein expression of
SMMHC on our perivascular cell derivatives. hiPSC con-
vSMCs exhibited the greatest expression of SMMHC
mRNA compared to all other cell types tested (Figure 3C,
ii). At the protein level, SMMHCwas only detected on con-
trol aortic vSMCs and hiPSC con-vSMCs (Figure 3C, iii);
hiPSC syn-vSMCs were negative for SMMHC. Interestingly,
SMMHCwas not detected in either hiPSC pericytes or con-
trol placental pericytes (Figure 3C, ii and iii). Finally, the
expression of caldesmon, which plays an important role
in the perivascular contraction function, was assessed in
the different types of perivascular cells. We found that
caldesmon was elevated in con-vSMCs compared to syn-
vSMCs and pericyte derivatives (Figure 3D). We note that
the expression of perivascular markers in aortic vSMCs
cultured in low serum (0.5%) conditions was slightly
altered yet exhibited a similar trend of aortic vSMCs
cultured in 10% serum and hiPSC con-vSMCs (Figure S4C).
ECM Protein Production
A primary function of perivascular cells is the deposition of
ECM proteins to help stabilize vasculature. Because the
ECM composition of various vessel types differs, we next
assessed the different perivascular cell types for expression
and production of ECM proteins collagen I, collagen IV,
fibronectin, laminin, and elastin in vitro (Figure 4). We
found that both phenotypes of vSMCs exhibited concen-
trated perinuclear collagen I expression, while hiPSC
pericytes demonstrated diffuse expression of collagen I
around the cytoplasm (Figure 4A, i). hiPSC syn-vSMCs
and hiPSC pericytes exhibited similar extracellular andSteglobular expression of collagen IV, while hiPSC con-vSMCs
had abundant fibrous intracellular and extracellular col-
lagen IV (Figure 4A, ii). hiPSC con-vSMCs deposited abun-
dant fibronectin extracellularly (Figure 4A, iii); though
abundant fibronectin production was detected by hiPSC
syn-vSMCs and pericytes, we observed fibronectin produc-
tion was primarily intracellular (Figure 4A, iii). Laminin
appeared perinuclearly around the three perivascular
derivatives (Figure 4A, iv). However, hiPSC pericytes ex-
hibited a punctate expression compared to the diffuse lam-
inin protein expression in vSMC derivatives (Figure 4A, iv).
Comparable deposition of ECM proteins was observed in
aortic vSMCs and placental pericytes (Figure S5A).
A mature vSMC marker implicated in the mechanical
responsiveness of vSMCs (Babu et al., 2000; Patel et al.,
2006), elastin was expressed primarily intracellularly and
diffusely within con-vSMCs, with some cells exhibiting
perinuclear characteristic disordered elastin expression
(Figure 4A, v). Correspondingly, aortic vSMCs exhibited
elastin expression with both intracellular and extracellular
deposition (Figure S5B). We could not detect elastin in
either hiPSC syn-vSMCs, or hiPSC pericytes (Figure 4A, v).
Corroborating our immunofluorescence data, we per-
formed RT-PCR analysis on the tested perivascular cells
(Figure 4B). We found an increased expression of collagens
I and IV and elastin by hiPSC con-vSMCs. Surprisingly,
hiPSC pericytes demonstrated the highest expression of
fibronectin and its extra domain A (ED-A fibronectin; Fig-
ure S5C), suggesting the propensity of the derived pericytes
to produce fibronectin under amenable in vitro culture
conditions. hiPSC con-vSMCs had higher levels of both
fibronectin and ED-A fibronectin than syn-vSMCs. Con-
vSMCs and aortic vSMCs exhibited the greatest expression
of both laminin and elastin compared to the other tested
perivascular cell types. Interestingly, aortic vSMCs had
lower expression of collagen I compared to hiPSC con-
vSMCs; placental pericytes exhibited lower expression of
collagen IV and fibronectin compared to hiPSC pericytes
(Figure 4B; Figure S5C). Finally, the hiPSC con-vSMCs ex-
pressed elastin mRNA 100-fold more than the hiPSC syn-
vSMCs and hiPSC pericytes (Figure 4B). We note that
elastin expression in aortic vSMCs was higher compared
to hiPSC con-vSMCs and increased when aortic vSMCs
were cultured in low serum, demonstrating the importance
of culture conditions for the derivation of perivascular cell
types from hiPSCs (Figure 4B; Figure S5D).
In the vasculature, there exists a wide range of matrix
metalloproteinases (MMPs), which are proteolytic enzymes
that degrade the ECM and remodel the architecture of asso-
ciated vessels. The degradation of ECM allows perivascular
cells to migrate and proliferate (Raffetto and Khalil, 2008).
Via zymography analysis, we found that only hiPSC syn-
vSMCs produce pro-MMP9. Both hiPSC syn-vSMCs andm Cell Reports j Vol. 2 j 561–575 j May 6, 2014 j ª2014 The Authors 565
Figure 3. Differences in Stress Fiber and Contractile Marker Expression
Perivascular derivatives were assessed for (A) (i) organization of stress fibers (confocal z-stacks), a-SMA, and calponin (in red; phalloidin
in green; nuclei in blue); (ii) stress fiber number and (iii) a-SMA and calponin expression via quantitative real time RT-PCR; (B) (i)
organization of NG2 (green) and a-SMA (red; nuclei in blue) and (ii) NG2 expression using quantitative real-time RT-PCR; (iii) (C) (i)
(legend continued on next page)
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while hiPSC con-vSMCs produce only the pro-MMP2 (Fig-
ure 4C, i). We could not detect MMP1 expression using
zymography (data not shown). Molecular analysis revealed
that hiPSC pericytes have greater MMP14 mRNA expres-
sion, while syn-vSMCs have the lowest expression (Fig-
ure 4C, ii).Functionality
In the body, the cellular dynamics of perivascular cells can
provide information regarding whether a vessel is emer-
gent, pathogenic, remodeling, or at a stable steady state.
Of particular functional importance are multipotency,
in vivo behavior, migration, invasion, and contractility of
perivascular cells.
Multipotency
A major feature of pericytes is their ability to behave as
mesenchymal precursors (Crisan et al., 2008). Indeed, our
previous studies have demonstrated that pericyte deriva-
tives could be differentiated to adipocytes and osteoblasts
(Kusuma et al., 2013). Contrastingly, neither hiPSC
con-vSMCs nor syn-vSMCs demonstrated the potential to
differentiate toward adipogenic or osteogenic lineages
(Figure 5A).
In Vivo Integration
To compare in vivo functionality, we employed a Matrigel
plug assay using our hiPSC perivascular cells. After 1 week
of subcutaneous transplantation, all three types of perivas-
cular cells aligned next to the host’s growing functional
vasculature, with occasional circumferential wrapping
observed by con-vSMCs and pericytes (Figure 5B) and
vascular tube narrowing observed only by con-vSMCs
(Kusuma et al., 2013; Wanjare et al., 2013a).
Migration
Mechanisms that induce cell motility include chemokine-
sis, chemotaxis, responses to interactions with ECM, and
random increases such as in wound healing (Louis and
Zahradka, 2010). In a wound-healing assay, hiPSC pericytes
and hiPSC syn-vSMCs migrated inward from the wound
margin (Figure 5C, i). hiPSC pericytes exhibited a signifi-
cant number of trajectories that were not perpendicular
to the wound margin, whereas hiPSC con-vSMCs followed
oriented trajectories predominantly toward the right.
Indeed, after 24 hr, wound closure was observed only
with the hiPSC syn-vSMCs (Figure 5C, i and ii). Overall,
the hiPSC con-vSMCs exhibited the slowest migration
speed (Figure 5C, iii).PDGFRb (green) and SMMHC (red; nuclei in blue) and (ii) PDGFRb an
cytometry analysis of SMMHC (isotype control in gray); and (D) calde
from three independent experiments; each RT-PCR sample was run
mean ± SEM. *p < 0.05, **p < 0.01, and ***p < 0.001. See also Figu
SteInvasion
Invasion is the cell motility associated with ECM degrada-
tion. To assess the ability of perivascular cells to invade
toward ECs, we cultured a monolayer of ECs beneath a
3D collagen gel. Each perivascular cell type was cultured
atop the collagen gel, and migration was measured after
48 hr. Human iPSC syn-vSMCs exhibited increased inva-
sion toward ECs after 48 hr compared to hiPSC con-vSMCs
and hiPSC pericytes (Figure 5D, i). Quantification of this
dynamic behavior further revealed not only that more
hiPSC syn-vSMCs invaded the collagen gels compared to
the other perivascular cells but also that they invaded to a
deeper distance (Figure 5D, ii and iii).
Contractility
In healthy blood vessels, perivascular cells provide stability
to vessels by contracting to counteract the pulsatile force
generated by heartbeats. Examining the contractility of
the three perivascular derivatives in response to the
cholinergic agonist drug carbachol, we found that hiPSC
con-vSMCs contracted significantly more than both hiPSC
pericytes and hiPSC syn-vSMCs (Figure 5E).DISCUSSION
Themajor function of both pericytes and vSMCs is to stabi-
lize blood vessels, and thus both exhibit a great deal of sim-
ilarities. Distinguishing among the three perivascular cells
will facilitate their use in tissue engineering applications.
Because pericytes are found in capillaries (<10 mm diam-
eter) andmicrovessels (10–100 mmdiameter), while vSMCs
are found in larger vessels (>100 mm diameter), we sought
to investigate methods that could elucidate similarities
and differences between pericytes and vSMCs in vitro.
In previous studies, we derived pericytes (Kusuma et al.,
2013) and both hiPSC syn-vSMCs and hiPSC con-vSMCs
(Wanjare et al., 2013a). In performing direct comparisons
between these perivascular cell derivatives, we observed
numerous differences that enable the study of human peri-
vascular development and functionality and may shed
light on means to not only distinguish between them but
also clearly define their functionality for future use in
tissue-regenerative strategies. A summary of the key fea-
tures compared among the perivascular derivatives from
hiPSC-BC1 is shown in Table 1.
By assessingmarker expression fromday 6 differentiating
cells compared to derived EVCs and SMLCs, wewere able to
label our day 6 cells as early mesoderm, characterized byd SMMHC expression using quantitative real-time RT-PCR; (iii) flow
smon expression via quantitative real-time RT-PCR. Results shown
with three technical replicates. All graphical data are reported as
res S3 and S4.
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Figure 4. Differential ECM and MMP Expression by Perivascular Derivatives
(A and B) Perivascular derivatives were examined for the production of ECM proteins (i) collagen I, (ii) collagen IV, (iii) fibronectin, (iv)
laminin, and (v) elastin (all in green; phalloidin in red; nuclei in blue) after 6 days in culture (A), and their relative expression via
quantitative real-time RT-PCR is shown (B).
(C) Perivascular derivatives were compared for (i) the production of MMP2 and MMP9 using zymography, and (ii) the relative expression of
MMP14 using quantitative real-time RT-PCR is shown.
Results from three independent experiments are shown; each RT-PCR sample was run with three technical replicates. All graphical data are
reported as mean ± SEM. *p < 0.05, **p < 0.01, and ***p < 0.001.
See also Figure S5.
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Perivascular Cells from hiPSCsexpression of CD56 and CD73. Via EVC differentiation,
day 6 cells differentiate into VEcad+ and PDGFRb+ cells
(Kusuma et al., 2013); in SMLC differentiation, day 6
cells were induced to differentiate into cells positive for
SMMHC, SM22, and calponin (Vo et al., 2010).
In vivo perivascular cell characteristics are dependent on
the local 3D cellular environment, which is composed of
cell-cell interactions, surrounding ECM, local mechanical
conditions, and chemical cues. While contractile vSMCs
are quiescent in the body, synthetic vSMCs display
increased proliferation in order to remodel vessels in
response to growth factors and cytokines released during
vessel injury or disease (Sprague and Khalil, 2009). The
in vitro cell culture supplement, serum, contains numerous
cytokines and growth factors among other chemokines
such as hormones, lipids, attachment factors, etc. (Brunner
et al., 2010). Therefore, hiPSC syn-vSMCs responded
in vitro just as the synthetic phenotype in the body with
high proliferation rates as they were exposed to these
different chemokines in serum. Although endothelial-peri-
cyte interactions have been studied extensively, pericyte-
pericyte interactions are not well understood. Here, we
show the colony-like growth of hiPSC pericytes, suggesting
that profound gap junction interactions are needed to acti-
vate contact inhibited proliferation of our hiPSC pericytes
(Li et al., 2003).
The ER is a major organelle involved in cell protein syn-
thesis. Although in vivo synthetic rat vSMCs have been
shown to increase their secretory apparatus that included
extensive active ER and Golgi complexes compared to con-
tractile vSMCs, in vitro we observe significant differences
in ER size (Thyberg et al., 1997). An in vivo study using
mice with knockout miR-143 and miR-145, microRNAs
that promote the contractile vSMC phenotype, reported
that mice aortas exhibited synthetic vSMC phenotypes
and dilated ER containing flocculent material (Elia et al.,
2009). In contrast, we show in vitro that hiPSC con-vSMCs
have dilated ER, hiPSC syn-vSMCs have nondilated ER, and
hiPSC pericytes have both types of ER. Expansion of the ER
in mammalian cells has been reported to be necessary in
order to accommodate increasing luminal content (mostly
unfolded proteins) as a result of ER stress or improper ER
function (Go¨rlach et al., 2006; Scho¨nthal 2012). Conse-
quently, the observed ER expansion may indicate that
serum deprivation activates vSMC contraction signaling
while halting ER-dependent protein synthesis, folding,
and transport signaling, thus creating a bottleneck in the
ER machinery and giving rise to the dilated appearance.
Because their ER machinery is a low priority, hiPSC con-
vSMCs therefore have accumulated unfolded proteins in
their dilated ER and are functionally dedicated to cell
contractility. Likewise, ER stress in the endothelium has
also been linked to the increased contraction of isolatedStemouse aortas (Liang et al., 2013). Liang et al. demonstrated
that there was greater phenylephrine-induced vasocon-
striction in the aortas of AMP-activated protein kinase
knockout mice (AMPKa2/), which exhibit aberrant ER
stress in ECs compared to WT mice (Liang et al., 2013).
The study may suggest that vSMCs not only functionally
contract more as a result of their own ER stress, but may
also respond in a similar manner in response to EC ER
stress. This correlation between ER stress and vSMC
contractility may additionally have a role in vessel diseases
such as atherosclerosis in which vSMCs take on a synthetic
phenotype and contraction is greatly reduced (Rzucidlo
et al., 2007). For instance, apoptosis of vSMCs as a result
of vSMC ER stress has been implicated in collagen produc-
tion in atherosclerotic lesions (Tabas, 2010). Therefore,
differences in ER signaling cues as well ER structure in our
hiPSC con-vSMCs and hiPSC syn-vSMCs may be helpful
in studying the diseased syn-vSMCs in vitro. Finally, the
proximity of mitochondria to the nucleus as well as the
presence of autophagosomes in both placental and hiPSC
pericytes, but not in hiPSC vSMCs,may also indicate differ-
ences in the cellular machinery of pericytes.
We also found clear differences in the amount of stress
fibers between the perivascular derivatives. Abundant
stress fibers were found in con-vSMCs located throughout
the entire cell body. While hiPSC syn-vSMCs had fewer
stress fibers, pericyte derivatives demonstrated the lowest
levels of stress fibers per cell and had stress fibers located
at the basal lateral surface. All perivascular cells expressed
a-SMA in similar levels while calponin was found to be
highly expressed in hiPSC pericytes, suggesting that this
typical early vSMC marker may also be helpful to identify
pericytes. Our findings also indicate that SMMHC is a
distinctive marker for con-vSMCs. Upregulated expression
and stress fiber organization of SMMHC were observed
in hiPSC con-vSMCs. The markers NG2 (or CSPG4) and
PDGFRb are widely utilized to identify pericytes; however,
vSMCs also express these markers, making it difficult to
distinguish which cell type is actually represented (Murfee
et al., 2005). NG2 has been observed to be expressed by
both pericytes and vSMCs in arterioles and capillaries,
but not beyond postcapillaries (along venules), in rats
(Murfee et al., 2005). Here, we showed that con-vSMCs
can be distinguished from pericytes and syn-vSMCs by
colocalization of NG2 with stress fibers.
The in vitro production and expression of ECM proteins
collagens I and IV and laminin differed between the peri-
vascular derivatives. In the body, pericytes produce ECM
in the subendothelial basement membrane of capillaries,
while both vSMCs and pericytes produce ECM in the
tunica media layer of larger blood vessels (Niland, 2009).
Collagen I, a fibrillar collagen, is a substantial component
of the interstitial connective tissue in contrast to collagenm Cell Reports j Vol. 2 j 561–575 j May 6, 2014 j ª2014 The Authors 569
(legend on next page)
570 Stem Cell Reports j Vol. 2 j 561–575 j May 6, 2014 j ª2014 The Authors
Stem Cell Reports
Perivascular Cells from hiPSCs
Table 1. Summary of Features Compared among hPSC-Derived Perivascular Cells
Cell Type/Features Con-vSMCs Syn-vSMCs Pericytes
Morphology large, spindle-like small, spindle-like colony-like, flat, polygonal
Proliferation rate + +++ +
Cell size +++ ++ +
Endoplasmic reticulum dilated nondilated dilated+ nondilated
Markers SMA, calponin, NG2, PDGFRb,
SMMHC
SMA, calponin, NG2, PDGFRb,
SMMHClow
SMA, calponin NG2, PDGFRb
ECM mRNA expression collagen Ihigh, collagen IVhigh ,
fibronectin, laminin
collagen I, collagen IV, fibronectin,
laminin
collagen I, collagen IV, fibronectinhigh,
laminin
ECM deposition collagen I, collagen IVfibrous,
fibronectin, laminindiffuse, elastin
collagen Ilow, collagen IVglobular,
fibronectin, laminindiffuse
collagen IVglobular, fibronectin,
lamininpunctuate
MMPs 14 (MT-1) 2, 9 2, 14
Mesenchymal differentiation — — adipogenic, osteogenic
In vivo integration alignment, circumferential
wrapping, tube narrowing
alignment alignment, circumferential wrapping
Migration /+ +++ ++
Invasion /+ +++ +
Contractility +++ + /+
Note that values are relative to the three cell types examined.
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Perivascular Cells from hiPSCsIV, which is present in all basal lamina, forming the basic
irregular fibrous 2D network of vasculature (Eble and
Niland, 2009). Similarly, laminin is an indispensible
component of the vascular basement membrane, the pri-
mary site where collagen IV and laminin form an interde-
pendent network (Eble and Niland, 2009). In human
arteries, collagen I, deposited between vSMCs, was reported
to exhibit sparse thin fiber morphology in the media of
small arteries while being organized in fibrillar structures
in larger arteries. We report that in vitro, hiPSC pericytes,
associated with small vasculature, have a greatly dimin-
ished collagen I expression compared to both hiPSC syn-
vSMCs and hiPSC con-vSMCs, found in larger vesselsFigure 5. Comparison of Functionalities Demonstrated by Perivas
(A) Differentiation potential of perivascular derivatives into mesench
(alizarin red S stain).
(B) One-week subcutaneously transplanted perivascular derivatives (i
ECs in green [Alexa 488-conjugated isolectin IB4]) within Matrigel, as
occasions of circumferential wrapping of vasculature by the transplan
(C) Migration potential via a wound-healing assay. Shown are (i) phas
(D) Downward invasion of hiPSC perivascular cells through collagen
toluidine blue-dyed cells and (ii) quantification of the cell number, d
(E) Contraction was induced by 105 M carbachol, and percent contr
Results shown from at least three biological replicates using three in
mean ± SEM. *p < 0.05, **p < 0.01, and ***p < 0.001.
Ste(Shekhonin et al., 1987). Both our in vitro findings and
in vivo studies illustrate that perivascular cells associated
with larger vessels express more collagen I. From our
in vitro study, we also observed that a morphologically
distinct high density globular collagen IV expression is
deposited by both hiPSC syn-vSMCs and pericytes, while
a more fibrous collagen IV deposition as well as increased
collagen IV expression is exhibited by hiPSC con-vSMCs.
Similarly, in vivo, collagen IV deposition varies between
the two phenotypes of vSMCs. For instance, fibrous pla-
ques of atherosclerotic human arteries, known to mainly
contain syn-vSMCs, have been reported to have greatly
decreased collagen IV deposition and increased collagen Icular Derivatives
ymal lineages including adipocytes (oil red O stain) and osteoblasts
n red; PKH26) migrated to newly formed host blood vessels (mouse
indicated by representative confocal images. White arrows indicate
ted hiPSC derivatives; nuclei are indicated in blue (DAPI).
e-contrast images quantified for (ii) cell trajectories and (iii) speed.
gels toward ECs was examined after 48 hr via (i) cross section of
istance of invasion, and (iii) the average distance traveled.
action was quantified.
dependent fields of view in each. All graphical data are reported as
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Perivascular Cells from hiPSCsdeposition around vSMCs compared to healthy arteries
containing contractile vSMCs (Rekhter, 1999; Shekhonin
et al., 1985, 1987). However, the loci of the plaques have
been shown to have large quantities of collagen IV, corre-
lating with the vSMCs being surrounded by layers of base-
ment membrane material in this region (Rekhter, 1999;
Shekhonin et al., 1987). Additionally, the in vitro laminin
expression was different in hiPSC pericytes compared to
both phenotypes of hiPSC vSMCs. hiPSC con-vSMCs had
diffuse cytoplasmic expression of laminin, while hiPSC
pericytes had punctate expression around the cell mem-
brane. hiPSC syn-vSMCs had mostly diffuse cytoplasmic
expression of laminin with few instances of punctate
expression. In vivo, rat synthetic vSMCs lost the ability to
produce laminin unlike contractile vSMCs (Thyberg et al.,
1997). Fibronectin was expressed and deposited by all
tested perivascular cell types, with hiPSC pericytes ex-
pressing the highest fibronectin mRNA levels. Human
iPSC con-vSMCs expressed higher levels of fibronectin
mRNA compared to hiPSC syn-vSMCs. Similarly, the
hiPSC con-vSMCs also expressed higher levels of ED-A
fibronectin compared to the hiPSC syn-vSMCs, while
in vivo, ED-A fibronectin was suggested to be associated
with the synthetic phenotype (Glukhova et al., 1989).
Examination of the expression pattern of ED-A fibro-
nectin in differentiating stem cells highlights the need
for further investigation of stem cell derivatives and the
conceivable differences between in vitro and reported
in vivo phenotypes, thus warranting additional studies
correlating fibronectin slice variants to perivascular phe-
notypes both in vitro and in vivo. Elastin was also highly
expressed by con-vSMCs compared to all other perivascu-
lar cell types. Not only is elastin production characteristic
of the contractile phenotype, but also, interestingly,
in vivo studies demonstrated that increasing elastin pro-
duction itself promoted a contractile vSMC phenotype
by inhibiting vSMC proliferation (Karnik et al., 2003;
Urba´n et al., 2002).
Pericytes and vSMCs have been known to express the
gelatinases MMP2 andMMP9 needed to degrade basement
membranes during vessel remodeling (Candelario-Jalil
et al., 2009; Newby, 2006; Virgintino et al., 2007). Accord-
ingly, in vitro, hiPSC syn-vSMCs expressed MMP2 and
MMP9, corresponding to previous observations that this
phenotype is associated with vessel remodeling, which in-
cludes ECM degradation. The expression of MMP2 and
MMP9 in hiPSC pericytes coincided with pericytes’ close
contact with basement membranes of vessels. A mem-
brane-associatedMMP,MMP14, wasmore greatly expressed
by derived pericytes compared to control placental peri-
cytes. MMP14 is known for its ability to degrade various
ECMproteins; thus, we had expected that control pericytes
would express this MMP type more greatly given the abun-572 Stem Cell Reports j Vol. 2 j 561–575 j May 6, 2014 j ª2014 The Authorsdance of these ECM proteins in microvessels and capil-
laries. We suspect the discrepancy may be due to a loss of
this site-specific feature due to in vitro culture of harvested
pericytes, emphasizing the advantages of derived perivas-
cular cell types over primary cells.
Not surprisingly, only hiPSC-derived pericytes had the
potential to differentiate to mesenchymal lineages, in-
cluding adipogenic and osteogenic, while neither hiPSC
nor vSMC types could differentiate. In vivo, all trans-
planted perivascular cells aligned next to the host vascula-
ture, with both pericytes and con-vSMCs occasionally
wrapping the microvasculature. These differences corre-
lated with in vivo phenotypes of these various perivascu-
lar cell types; both pericytes and con-vSMCs support
vasculature in vivo and are thus closely associated with
the endothelial lining, providing support. Syn-vSMCs,
alternatively, are known for their role in remodeling
vasculature. Differences in cellular mechanics may also
be used to distinguish among the three different peri-
vascular cell types. hiPSC syn-vSMCs were able migrate
in response to wounding and invade through ECM
toward ECs, whereas hiPSC con-vSMCs were not. Interest-
ingly, while the hiPSC pericytes migrated in response to
wounding, they failed to invade through ECM toward
ECs, indicative of their short-distance migratory nature.
This result coincides with the fact that pericytes have a
close spatial relation to ECs in vessels (Dı´az-Flores et al.,
2009).
Finally, hiPSC con-vSMCs can be characterized by their
elevated cellular contractility (as demonstrated by both
carbachol treatment and increased expression of contrac-
tile protein [caldesmon]), while hiPSC syn-vSMCs are char-
acterized by increased speed, migration, and invasion.
These results are in agreement with previous observations
that vSMCs switch to a synthetic phenotype in the body
in response to injury to aid in tissue repair (Louis and Zah-
radka, 2010).
In summary, these perivascular derivatives demonstrate
an important building block toward not only reconstruct-
ing physiologically relevant vasculature but also the study
of developmental processes and diseases implicating these
cell types. Important elements of our system are the several
noted discrepancies between our in vitro results and in vivo
phenotypes, alluding to the complexity of the field. A
major challenge of correlating in vitro results to pheno-
types observed in vivo is the presence of heterogeneous
vSMC subpopulations of unknown origin that lie between
the contractile and synthetic phenotypic spectrum in vivo.
Unanswered questions, particularly those regarding the
in vivo synthetic phenotype, still remain. For instance,
ECM deposition of syn-vSMCs located in vastly different
environments such as normal developing or remodeling
vessels compared to diseased or injured vessels remains
Stem Cell Reports
Perivascular Cells from hiPSCsunknown. To further add to the complication, by utilizing
SMMHC lineage tracing, Tang et al. reported that synthetic
vSMCs actually arise from multipotent stem cells lying
within vessels and not phenotypic switching by vSMCs
in vivo (Drukker et al., 2012; Tang et al., 2012). The advan-
tage of our study is the derivation and comparison of syn-
thetic and contractile vSMCs from a known common early
smooth muscle precursor. In fact, some of our study’s
in vitro results actually yield a more useful phenotype for
engineering blood vessels, such as increased ECM produc-
tion from the hiPSC derivatives compared to control cell
lines; however, other discrepancies, such as lower expres-
sion of fibronectin splice variant ED-A in derived syn-
vSMCs compared to con-vSMCs, drive the need for
continued study on the derivation of specialized cell types
to rebuild tissue. Additionally, studies in a 3D environment
would allow further investigation of morphological fea-
tures such as nucleic size that may better match in vivo
properties.
Overall, the ability to generate human perivascular cells
including contractile vSMCs, synthetic vSMCs, and peri-
cytes with identical genetic backgrounds offers unprece-
dented opportunities to study the development and
functionality of well-defined human perivascular deriva-
tives from healthy and disease hiPSCs. Furthermore, by
employing a viral integration-free and fully genetically
sequenced hiPSC line, BC1, we anticipate that these find-
ings hold translational importance.EXPERIMENTAL PROCEDURES
Complete experimental procedures are available online (see the
Supplemental Experimental Procedures).
Cell Culture
hiPSC Line and Differentiation
The hiPSC line BC1 (Cheng et al., 2012; Chou et al., 2011; kindly
provided by Dr. Cheng, SOM JHU) and the hESC line H9 were
expanded and differentiated to perivascular cells as described pre-
viously (Kusuma et al., 2013; Wanjare et al., 2013a).
Stress Fiber Quantification
The number of stress fibers per cell was quantified using line inten-
sity profiles of cells in ImageJ (Wei et al., 2011). Stress fibers were
labeled with fluorescent Alexa 488 phalloidin and imaged at 203
and 403. A line-intensity profile across a single cell was generated,
with each peak representing a single stress fiber.
Invasion toward ECs
A downward invasion assay was used to assess invasion of perivas-
cular cells. Human umbilical vein ECs were seeded on 16-well
detachable wells (Fisher). After 24 hr, 150 ml of collagen gel
(150 ml) was added on top of the ECs. After 1 hr, hiPSCs perivascular
cells were seeded on top of the gels. After 48 hr, the gels were fixed
and stained with toluidine blue dye and cross sections of the gels
were imaged and quantified.SteSUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and Supplemental
Experimental Procedures and can be found with this article online
at http://dx.doi.org/10.1016/j.stemcr.2014.03.004.
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